Canaan (CAN) EBITDA (2018 - 2026)

Canaan has disclosed EBITDA across 9 years of filings, most recently posting -$83.6 million for Q1 2026.

• In Q1 2026, EBITDA rose 4.48% year-over-year to -$83.6 million; the TTM figure through Mar 2026 stood at -$205.5 million (up 32.93% YoY), while the FY2025 annual figure was -$209.5 million, up 20.46% from the prior year.
• EBITDA held at -$83.6 million in Q1 2026, from -$83.9 million in the prior quarter.
• Over the last five years, EBITDA for CAN reached as high as $71.7 million in Q1 2022 and fell as low as -$139.3 million in Q4 2023.
• The 5-year median for EBITDA is -$72.4 million (2023), against an average of -$55.5 million.
• Annual changes were most pronounced in 2022 — EBITDA soared 13074.63% — and 2023, when it plunged 308.1%.
• A 5-year view of EBITDA shows it stood at -$83.0 million in 2022, then sank by 67.9% to -$139.3 million in 2023, then gained by 26.32% to -$102.6 million in 2024, then grew by 18.24% to -$83.9 million in 2025, then rose by 0.4% to -$83.6 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered -$83.6 million, -$83.9 million, and -$28.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.